EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
Scope & Guideline
Transforming Ideas into Impactful Medicinal Solutions.
Introduction
Aims and Scopes
- Drug Design and Discovery:
The journal publishes research on the design and synthesis of new drug candidates, highlighting innovative strategies for targeting various diseases, including cancer, infectious diseases, and metabolic disorders. - Structure-Activity Relationship (SAR) Studies:
A significant focus is placed on SAR studies, which investigate the relationship between chemical structure and biological activity to optimize the efficacy and selectivity of drug candidates. - Targeted Protein Degradation:
The journal features studies on PROTACs (proteolysis-targeting chimeras) and other modalities that aim to induce targeted degradation of specific proteins, offering a novel approach to cancer therapy and beyond. - Nanotechnology in Drug Delivery:
Research on nanotechnology applications in enhancing drug delivery systems, improving bioavailability, and targeting specific tissues or cells is a prominent theme. - Natural Products and Derivatives:
The journal explores the medicinal properties of natural products and their synthetic derivatives, investigating their potential as therapeutic agents and the mechanisms of action involved. - Multitarget Approaches:
There is a growing emphasis on the development of multitarget drugs that can simultaneously interact with multiple biological pathways, enhancing therapeutic efficacy and reducing resistance. - Computational Chemistry:
The integration of computational methods for predicting interactions, optimizing lead compounds, and informing synthetic strategies is a key component of the research published in the journal.
Trending and Emerging
- Targeted Protein Degradation Technologies:
The rise of PROTACs and other targeted degradation technologies is a significant trend, with increasing numbers of papers focusing on the design and application of degraders for therapeutic purposes. - Immunotherapy and Immune Modulation:
There is an emerging focus on small molecules that modulate immune responses, particularly in the context of cancer therapy, highlighting the intersection of medicinal chemistry and immunology. - Artificial Intelligence in Drug Discovery:
The integration of artificial intelligence and machine learning in drug discovery processes is gaining traction, with research exploring how these technologies can accelerate the identification of lead compounds. - Nanomedicine and Drug Delivery Systems:
Research that emphasizes the development of nanotechnology-based drug delivery systems is on the rise, focusing on improving the delivery and efficacy of therapeutics while minimizing side effects. - Multifunctional Therapeutics:
Emerging interest in multifunctional drugs that target multiple pathways or mechanisms simultaneously is evident, reflecting a shift towards more comprehensive therapeutic strategies. - Natural Product Derivatives with Enhanced Activities:
The exploration of derivatives of natural products, particularly those with optimized pharmacological profiles, is increasingly common as researchers seek to harness the therapeutic potential of these compounds. - Research on Metabolic Disorders:
A growing number of studies are addressing metabolic disorders, including diabetes and obesity, with a focus on discovering new therapeutic agents that can effectively manage these conditions.
Declining or Waning
- Traditional Small Molecule Inhibitors:
Research focusing solely on traditional small molecule inhibitors without integrating newer methodologies, such as PROTACs or nanotechnology, seems to be less frequent as the field evolves towards more innovative therapeutic approaches. - Single Target Drug Development:
There is a noticeable decline in publications centered around single-target drug development. The trend is shifting towards multitarget strategies that address the complexity of diseases, particularly in cancer and chronic conditions. - Synthetic Pathway Optimization:
Publications dedicated exclusively to optimizing synthetic pathways without a strong emphasis on biological evaluation are becoming less common, as researchers increasingly prioritize bioactivity and therapeutic relevance in their studies. - Basic Pharmacology Studies:
Basic pharmacological studies that do not explore clinical implications or translational potential are appearing less frequently, reflecting a growing expectation for research to connect laboratory findings with clinical applications.
Similar Journals
Research Journal of Pharmacognosy
Bridging the gap between herbal wisdom and modern science.Research Journal of Pharmacognosy, published by the Iranian Society of Pharmacognosy, is a pioneering forum for the dissemination of research in the field of pharmacognosy and its related disciplines. Founded in 2014 as an Open Access journal, it aims to provide swift and free access to high-quality research articles, fostering collaboration and innovation among researchers, professionals, and students. Operating from Tehran, Iran, this journal addresses a wide range of topics including complementary and alternative medicine, drug discovery, and organic chemistry, making it an invaluable resource for those researching the extraction, characterization, and application of naturally derived compounds. The journal holds a Category Quartile ranking of Q3 in Complementary and Alternative Medicine and Q4 in both Drug Discovery and Organic Chemistry for the year 2023, which underscores its growing influence within the scientific community. By serving as a platform for current advances and thought leadership in pharmacognosy, the Research Journal of Pharmacognosy plays a crucial role in bridging the gap between traditional practices and modern pharmacological applications.
European Journal of Medicinal Chemistry Reports
Exploring the frontiers of chemistry and molecular medicine.European Journal of Medicinal Chemistry Reports, published by ELSEVIER, is a vital platform dedicated to advancing the field of medicinal chemistry through open access communication of high-quality research. With an impact factor reflecting its growing influence, this journal has rapidly established a reputation for scholarly excellence since its launch in 2021. It serves as a converging point for innovative studies and reviews that span the disciplines of chemistry and molecular medicine, reflected in its Q2 and Q3 quartile rankings in relevant categories for 2023. Situated in France, the journal is accessible globally, ensuring that researchers, professionals, and students can easily engage with significant findings and methodologies in medicinal chemistry. The open access model facilitates the dissemination of knowledge, bridging gaps between laboratory research and practical applications in drug development. By fostering collaboration and highlighting emerging trends, the European Journal of Medicinal Chemistry Reports plays a crucial role in shaping the future of therapeutic innovations.
Anti-Cancer Agents in Medicinal Chemistry
Exploring the intersection of chemistry and cancer research.Anti-Cancer Agents in Medicinal Chemistry is a pivotal journal in the realm of cancer research, published by Bentham Science Publishers in the United Arab Emirates. With an ISSN of 1871-5206 and an E-ISSN of 1875-5992, this esteemed journal has been disseminating high-quality research since its inception in 2006, and is set to continue through 2024. The journal is categorized in the third quartile (Q3) across key areas including Cancer Research, Molecular Medicine, and Pharmacology, highlighting its essential role in providing valuable insights to the scientific community. Despite its open-access status being unspecified, researchers benefit from the rigorous peer-review process ensuring the publication of significant advancements. The journal ranks well within Scopus, particularly in the fields of Pharmacology and Cancer Research, which positions it as a notable resource for professionals, students, and researchers aiming to deepen their knowledge in anti-cancer strategies. Through its comprehensive scope, the journal aims to bridge the gap between medicinal chemistry and clinical applications, making it an indispensable tool for those dedicated to advancing cancer therapeutics.
CURRENT DRUG TARGETS
Unraveling the Complexities of Drug ActionCURRENT DRUG TARGETS is a leading peer-reviewed journal dedicated to advancements in the fields of Clinical Biochemistry, Drug Discovery, Molecular Medicine, and Pharmacology. Published by Bentham Science Publishers Ltd, this esteemed journal has solidified its position in the academic community with a 2023 Q2 ranking in several categories, highlighting its influence and relevance in drug research and development. With an ISSN of 1389-4501 and E-ISSN 1873-5592, CURRENT DRUG TARGETS facilitates the dissemination of high-quality articles that explore novel therapeutic strategies and drug design principles. Catered to researchers, professionals, and students, the journal has a commitment to advancing knowledge while addressing contemporary challenges in pharmacological sciences. As it converges from 2000 to 2024, CURRENT DRUG TARGETS remains a vital resource in understanding the complexities of drug action and interaction, making it indispensable for anyone pursuing cutting-edge research in related disciplines.
ARCHIV DER PHARMAZIE
Elevating Standards in Pharmaceutical ResearchARCHIV DER PHARMAZIE is a prestigious journal published by WILEY-V C H VERLAG GMBH, dedicated to pioneering advances in the fields of Pharmaceutical Science and Drug Discovery. With an impactful history dating back to its inception in 1822, this journal is recognized for its significant contribution to the pharmaceutical sciences, maintaining an impressive Q2 ranking in both the Drug Discovery and Pharmaceutical Science categories as of 2023. The journal’s commitment to excellence is reflected in its Scopus rankings, placing it in the top tiers of relevant fields, ensuring a broad reach and impact among researchers and professionals. Although Open Access options are not available, ARCHIV DER PHARMAZIE continues to be an invaluable resource for scholars seeking to stay abreast of cutting-edge research and developments in pharmacy and related sciences. The journal’s contributions not only serve as crucial benchmarks in research but also enhance the understanding of pharmaceutical innovations, making it essential reading for both seasoned professionals and students alike.
RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY
Fostering Collaboration in Life Sciences ResearchRussian Journal of Bioorganic Chemistry (ISSN: 1068-1620, E-ISSN: 1608-330X), published by MAIK Nauka/Interperiodica/Springer, serves as a vital resource for researchers and professionals in the fields of bioorganic chemistry, biochemistry, and organic chemistry. With a focus on the integration of organic chemistry principles with biological processes, this journal aims to disseminate significant findings and advancements from both theoretical and practical perspectives. Although currently not open access, the journal retains a dedication to high-quality, peer-reviewed content, contributing to its reputation within the academic community. The 2023 Scopus rankings position it within the Q4 category for both biochemistry and organic chemistry, indicating its critical niche within these disciplines amid a competitive landscape. Since its inception in 1996, the journal has continued to evolve, providing enriching insights and fostering collaborations among scholars and practitioners alike, with publication converging up to the year 2024. By exploring complex biomolecular interactions and the synthesis of biologically relevant compounds, the Russian Journal of Bioorganic Chemistry remains a significant platform for advancing knowledge and innovation in the life sciences.
Heterocyclic Letters
Showcasing Breakthroughs in Heterocyclic CompoundsHeterocyclic Letters is an esteemed journal in the field of synthetic organic chemistry, published by RAMAN PUBL. With ISSN 2231-3087 and E-ISSN 2230-9632, this journal aims to disseminate original research and innovative findings related to heterocyclic compounds, which play a crucial role in medicinal chemistry, material science, and agricultural chemistry. Heterocyclic Letters provides a platform for researchers, professionals, and students to share their insights and advancements, thus fostering academic collaboration and knowledge transfer. The journal is dedicated to maintaining high-quality standards in research publication, making it an essential resource for anyone focused on the latest developments in heterocyclic chemistry. Although it does not currently offer Open Access options, the journal’s rigorous peer-review process ensures that only the most credible and impactful studies are published, contributing significantly to the advancement of the field.
ChemMedChem
Pioneering insights for the next generation of pharmaceuticals.ChemMedChem is a leading international journal published by WILEY-V C H VERLAG GMBH in the United Kingdom, specializing in the interdisciplinary fields of medicinal chemistry and drug discovery. With a commendable impact factor that places it in the Q1 quartile for Organic Chemistry and among the Q2 ranks in several other key categories including Biochemistry, Molecular Medicine, and Pharmacology, ChemMedChem serves as a vital platform for the dissemination of innovative research and transformative insights in the development of pharmaceutical agents. Since its inception in 2006, this journal has been at the forefront of advancing knowledge that bridges the gap between fundamental research and practical applications in medicine, making it an essential resource for researchers, professionals, and students alike. Although it currently does not offer Open Access options, the journal ensures high-quality peer-reviewed content that engages its audience and fosters collaborative scientific discourse.
MEDICINAL RESEARCH REVIEWS
Transforming Research into Revolutionary TherapeuticsMEDICINAL RESEARCH REVIEWS, published by Wiley, is a leading journal in the fields of Drug Discovery, Molecular Medicine, and Pharmacology. With an impressive impact factor and esteemed standing in its category quartiles (Q1 in all three fields), this journal serves as a vital platform for the dissemination of cutting-edge research and reviews that drive innovation in therapeutic development and molecular health sciences. Since its inception in 1981, MEDICINAL RESEARCH REVIEWS has garnered a robust readership within the scientific community, underscored by its high rankings in Scopus – where it ranks #3 in Pharmacology and #2 in Drug Discovery, placing it within the top echelons of academic influence. Researchers, professionals, and students alike benefit from its rich content and comprehensive approaches to tackling complex medicinal challenges, making it an essential resource for those invested in advancing the frontiers of biomedical research.
Future Medicinal Chemistry
Exploring innovative solutions in medicinal chemistry.Future Medicinal Chemistry is a premier journal dedicated to the rapidly evolving fields of drug discovery, pharmacology, and molecular medicine. Published by Newlands Press Ltd in the United Kingdom, this journal has garnered significant attention within the academic community, evidenced by its 2023 category rankings in Scopus, placing it in the Q2 quartile for Drug Discovery and the Q3 quartiles for both Molecular Medicine and Pharmacology. With an ISSN of 1756-8919 and an E-ISSN of 1756-8927, Future Medicinal Chemistry has been a cornerstone of scholarly discourse since its inception in 2009, continuously contributing to the advancement of knowledge and discussion in medicinal chemistry. The journal is committed to publishing high-quality, peer-reviewed research that addresses the challenges and innovations in drug development and therapeutic strategies, making it an essential resource for researchers, professionals, and students seeking to stay at the forefront of these critical fields. Engage with the latest findings and methodologies that shape the future of medicine by exploring the wealth of information offered within Future Medicinal Chemistry.